MannKind Corporation (MNKD) Stock Forecast

NASDAQ: MNKDAnalyst ratings, price target and estimates.

MNKD analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.75 / 5 from 8 analysts
Price target
$7.84
average of analyst targets
Upside to target
+158.0%
from the latest close
Next earnings
November 4, 2026
EPS estimate $-0.08
52-week range
$2.28 – $6.21

MNKD analyst ratings

8 analysts
Strong buy
788%
Buy
00%
Hold
112%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

MNKD price target

Price $3.04Target $7.84
52-week low $2.2852-week high $6.21

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

MNKD earnings per share estimates

MannKind Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.01−$0.04$0.01$0.07−107.1%4
Current fiscal year (2026)$0.03$0.01$0.04$0.19−84.2%4
Next fiscal year (2027)$0.13$0.05$0.20$0.03+325.0%4

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

MNKD revenue estimates

MannKind Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$110.3M$102.9M$118.0M+34.3%8
Current fiscal year (2026)$444.7M$428.2M$459.2M+27.4%8
Next fiscal year (2027)$505.7M$436.4M$560.1M+13.7%8

MNKD EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

MNKD revenue: reported and forecast

Reported revenueEstimate (average; low–high)

MNKD EPS estimate revisions

MannKind Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$0.02−$0.01−$0.01−$0.01−$0.01−125.0%0 up · 0 down
Current fiscal year (2026)$0.09$0.03$0.03$0.03$0.03−64.7%0 up · 0 down
Next fiscal year (2027)$0.19$0.13$0.13$0.13$0.13−33.8%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

MNKD earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; MNKD beat in 4 of 12.

What analysts expect from MNKD

8 analysts cover MannKind; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.84, 158.0% above the latest close of $3.04. Analysts expect earnings of $0.03 per share for 2026, −84.2% from a year earlier. For 2027 the average estimate is $0.13 per share on revenue of $505.7 million. MannKind beat the EPS estimate in 4 of the last 12 quarters.

Related: MNKD income statement, MNKD key metrics, MNKD chart. See the MNKD stock overview for the latest quote and news.

MNKD forecast FAQ

What is MannKind's price target?

The average analyst price target for MannKind is $7.84, 158.0% above the latest close of $3.04.

Is MannKind a buy, hold or sell?

Of 8 analysts covering MannKind, 7 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is MannKind's EPS forecast?

Analysts forecast $0.03 per share for 2026 (range $0.01 to $0.04); for 2027 the estimate is $0.13.

What is MannKind's revenue forecast?

The average revenue estimate for 2026 is $444.7 million, growth of 27.4%; for 2027 it is $505.7 million.

When does MannKind report earnings?

MannKind is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $-0.08.

Does MannKind usually beat earnings estimates?

MannKind reported EPS at or above the analyst estimate in 4 of the last 12 quarters.

Biotechnology: forecast